Dr. Jess Silva-Fisher
@jesssfisher.bsky.social
RNA biologist, Cancer expert, leader and mentor, Tejana, WashU Med, silvafisherlab.com
Reposted by Dr. Jess Silva-Fisher
Check how this study highlights LINC01432 as a potential therapeutic target for overcoming resistance in high-risk multiple myeloma.
November 4, 2025 at 8:02 AM
Check how this study highlights LINC01432 as a potential therapeutic target for overcoming resistance in high-risk multiple myeloma.